The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Elevance Health Inc shares valued at $183,903 were sold by Penczek Ronald W on Mar 10 ’25. At $415.13 per share, Penczek Ronald W sold 443 shares. The insider’s holdings dropped to 1,847 shares worth approximately $0.81 million following the completion of this transaction.
Also, Penczek Ronald W purchased 443 shares, netting a total of over 183,904 in proceeds.
Before that, Kendrick Charles Morgan JR had sold 3,504 shares from its account. In a trade valued at $1,388,635, the EVP & President, Commercial traded Elevance Health Inc shares for $396.30 each. Upon closing the transaction, the insider’s holdings decreased to 3,504 shares, worth approximately $4.41 million.
As published in a research note from Argus on March 17, 2025, Elevance Health Inc [ELV] has been rated up from a Hold to a Buy and the price target has been revised to $450. Analysts at Stephens downgraded the stock from ‘”an Overweight”‘ to ‘”an Equal-weight”‘ outlook in a report released in late January. As of October 18, 2024, Argus has decreased its “Buy” rating to a “Hold” for ELV. Earlier on July 18, 2024, BofA Securities downgraded its rating. Their new recommendation was “a Neutral” for ELV stock which previously was a “a Buy”.
Analyzing ELV Stock Performance
During the last five days, there has been a drop of approximately -3.61%. Over the course of the year, Elevance Health Inc shares have jumped approximately 18.29%. Shares of the company reached a 52-week high of $458.75 on 04/08/25 and a 52-week low of $364.61 on 01/02/25. A 50-day SMA is recorded $410.90, while a 200-day SMA reached $453.37.
Support And Resistance Levels for Elevance Health Inc (ELV)
According to the 24-hour chart, there is a support level at 428.32, which, if violated, would cause prices to drop to 420.26. In the upper region, resistance lies at 444.40. The next price resistance is at 452.42. RSI (Relative Strength Index) is 56.88 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.19, which suggests the price will increase in the coming days. Percent R is at 47.89%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
